{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"0","upperLimit":"13.7","value":"0"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"25"}],"units":"Participants"}],"title":"HPV positive SCCHN"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"0","upperLimit":"13.7","value":"0"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"25"}],"units":"Participants"}],"title":"HPV negative SCCHN"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"0.2","upperLimit":"36.0","value":"7.7"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"13"}],"units":"Participants"}],"title":"Cervical Carcinoma"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"0.0","upperLimit":"26.5","value":"0"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"12"}],"units":"Participants"}],"title":"Vaginal/Vulvar Carcinoma"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"0.1","upperLimit":"14.2","value":"2.7"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"37"}],"units":"Participants"}],"title":"Merkel Cell Carcinoma"}],"denoms":[{"counts":[{"groupId":"OG000","value":"112"}],"units":"Participants"}],"description":"Rate of surgery delay is defined as the percentage of participants in the neoadjuvant cohort with surgery delayed \\> 4 weeks from the planned surgery date or planned start date for chemoradiation due to a drug-related adverse event.\n\nParticipants with the following diseases will be assessed:\n\n1. HPV positive squamous cell carcinoma of the Head and Neck (SCCHN);\n2. HPV negative SCCHN;\n3. Cervical Carcinoma;\n4. Vaginal/Vulvar Carcinoma;\n5. Merkel Cell Carcinoma","dispersionType":"95% Confidence Interval","groups":[{"description":"Nivolumab administered intravenously (IV) over 30 minutes at 240 mg for 2 doses, on Day 1 and Day 15","id":"OG000","title":"Neoadjuvant"}],"paramType":"NUMBER","populationDescription":"All tumor reduction evaluable participants in the neoadjuvant cohort","reportingStatus":"POSTED","timeFrame":"Day 29","title":"Neoadjuvant: Rate of Surgery Delay","type":"PRIMARY","unitOfMeasure":"Percentage of participants"}